A comprehensive analysis of immunotherapy in advanced endometrial cancer (Review).

ABSTRACT: The morbidity and mortality rates of endometrial cancer (EC) are increasing yearly. Early-stage EC can be effectively treated through surgery or surgery combined with radiotherapy and chemotherapy. Advanced and recurrent EC is treated with chemotherapy and comprehensive treatment; however, the prognosis for patients at this disease stage is poor. Consequently, novel and effective treatment strategies are urgently required for these patients. Breakthrough progress has been made with the use of immunosuppressants in the treatment of EC, which have been included in treatment guidelines. In the present review, the etiology and classification of EC was outlined and the relevant scientific basis for the application of immunosuppressants in advanced and recurrent EC was discussed. The relevant pu

SUBMITTER: Wang L 

PROVIDER: S-EPMC10773226 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature